Journal
NATURE REVIEWS ENDOCRINOLOGY
Volume -, Issue -, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41574-022-00769-1
Keywords
-
Categories
Funding
- Novo Nordisk Foundation [NNF18CC0034900]
Ask authors/readers for more resources
Classic psychedelics are being reconsidered as novel drug candidates for disorders like depression and addiction. The neurobiological similarities between facets of obesity pathophysiology and these conditions suggest that obesity could be the next frontier in psychedelic research.
Classic psychedelics are being revisited as novel drug candidates. Researchers are investigating the efficacy of psychedelics for disorders such as depression and addiction. Facets of obesity pathophysiology are neurobiologically similar to these conditions, and we propose that obesity could be the next frontier in psychedelic research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available